GlaxoSmithKline (GSK) is permanently discontinuing retigabine (Trobalt) from June 2017. It will no longer be available after June.
GSK announced their plan to discontinue Trobalt last year. If you take Trobalt your epilepsy specialist should have already discussed stopping this treatment, and possibly switching to another medicine instead. If you have not already talked to your doctor about stopping Trobalt, it’s important to contact them as soon as possible. This is so you have time to safely stop taking it before stocks run out.